IN2015DN03065A - - Google Patents
Info
- Publication number
- IN2015DN03065A IN2015DN03065A IN3065DEN2015A IN2015DN03065A IN 2015DN03065 A IN2015DN03065 A IN 2015DN03065A IN 3065DEN2015 A IN3065DEN2015 A IN 3065DEN2015A IN 2015DN03065 A IN2015DN03065 A IN 2015DN03065A
- Authority
- IN
- India
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261716790P | 2012-10-22 | 2012-10-22 | |
PCT/US2013/065829 WO2014066204A1 (en) | 2012-10-22 | 2013-10-21 | Combination |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2015DN03065A true IN2015DN03065A (en) | 2015-10-02 |
Family
ID=50545139
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN3065DEN2015 IN2015DN03065A (en) | 2012-10-22 | 2015-04-13 |
Country Status (12)
Country | Link |
---|---|
US (1) | US20150272950A1 (en) |
EP (1) | EP2908816A4 (en) |
JP (1) | JP2015534987A (en) |
KR (1) | KR20150073989A (en) |
CN (1) | CN104736154A (en) |
AU (1) | AU2013334945A1 (en) |
BR (1) | BR112015008681A2 (en) |
CA (1) | CA2888976A1 (en) |
IN (1) | IN2015DN03065A (en) |
MX (1) | MX2015005114A (en) |
RU (1) | RU2015119226A (en) |
WO (1) | WO2014066204A1 (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL2485593T3 (en) * | 2009-10-08 | 2015-06-30 | Novartis Ag | Combination |
WO2011150044A1 (en) * | 2010-05-26 | 2011-12-01 | Glaxosmithkline Llc | Combination |
US20130004481A1 (en) * | 2011-01-12 | 2013-01-03 | Boehringer Ingelheim International Gmbh | Anticancer therapy |
CN103476413B (en) * | 2011-01-26 | 2016-03-16 | 葛兰素史密斯克莱知识产权有限公司 | Combination |
-
2013
- 2013-10-21 WO PCT/US2013/065829 patent/WO2014066204A1/en active Application Filing
- 2013-10-21 CA CA2888976A patent/CA2888976A1/en not_active Abandoned
- 2013-10-21 EP EP13848603.0A patent/EP2908816A4/en not_active Withdrawn
- 2013-10-21 KR KR1020157010002A patent/KR20150073989A/en not_active Application Discontinuation
- 2013-10-21 CN CN201380055237.3A patent/CN104736154A/en active Pending
- 2013-10-21 US US14/437,311 patent/US20150272950A1/en not_active Abandoned
- 2013-10-21 RU RU2015119226A patent/RU2015119226A/en unknown
- 2013-10-21 JP JP2015538099A patent/JP2015534987A/en active Pending
- 2013-10-21 MX MX2015005114A patent/MX2015005114A/en unknown
- 2013-10-21 BR BR112015008681A patent/BR112015008681A2/en not_active IP Right Cessation
- 2013-10-21 AU AU2013334945A patent/AU2013334945A1/en not_active Abandoned
-
2015
- 2015-04-13 IN IN3065DEN2015 patent/IN2015DN03065A/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP2908816A4 (en) | 2016-06-15 |
MX2015005114A (en) | 2015-07-17 |
US20150272950A1 (en) | 2015-10-01 |
RU2015119226A (en) | 2016-12-10 |
AU2013334945A1 (en) | 2015-04-23 |
KR20150073989A (en) | 2015-07-01 |
EP2908816A1 (en) | 2015-08-26 |
JP2015534987A (en) | 2015-12-07 |
BR112015008681A2 (en) | 2017-07-04 |
WO2014066204A1 (en) | 2014-05-01 |
CA2888976A1 (en) | 2014-05-01 |
CN104736154A (en) | 2015-06-24 |